Bigger India
US SEC Charges Indian-origin Scientist For Insider Trading
After he learned that his company was about to acquire life sciences company Senquenom, Madan purchased 9,300 shares of Sequenom despite company insider trading policy.
An Indian-origin scientist has agreed to settle charges that he engaged in insider trading after learning that his company was about to acquire a life sciences company.
Anup Madan, 52, of Washington was a principal scientist with LabCorp’s Covance Genomics Laboratory.